Related by context. Frequent words. (Click for all words.) 73 proteasome inhibitor 71 Lubiprostone 70 HGS ETR2 70 Carfilzomib 70 refractory chronic lymphocytic 70 Initiate Phase 70 Aliskiren 69 Golimumab 69 PEG SN# 69 Dasatinib 69 Recombinant Human 69 Pivotal Phase III 69 Initiates Phase II 69 AEG# 69 Epratuzumab 69 Voreloxin 69 Epidermal Growth Factor Receptor 69 tigecycline 69 ISTODAX 68 Talactoferrin 68 Panzem R 68 liposomal formulation 68 Perifosine 68 Azedra 68 oropharyngeal candidiasis 68 darinaparsin 67 Antifungal 67 ThermoDox R 67 R sorafenib tablets 67 forodesine 67 oral candidiasis 67 TLR9 agonist 67 murine model 67 Microspheres 67 cytostatic 67 Onalta 67 Irinotecan 67 DermaVir 67 Daclizumab 67 Pralatrexate 67 antitumor effects 67 Vandetanib 66 Clinical Trial Results 66 Taxol ® 66 Cetrorelix 66 DAVANAT 66 calcineurin inhibitors 66 Ambrisentan 66 Clevudine 66 Crofelemer 66 polymerase inhibitor 66 Monoclonal Antibody 66 radiolabeled 66 Metastatic Melanoma 66 Traficet EN 66 Erlotinib 66 Dapagliflozin 66 immune modulator 66 #ME# 66 efalizumab 66 Lacosamide 66 Bortezomib 66 selective inhibition 66 MEK inhibitor 66 Fenofibrate 66 Laquinimod 66 PCK# 66 BNC# 66 proteasome inhibitors 66 Tesetaxel 66 KRN# 66 Elesclomol 66 Coadministration 66 Drug Candidate 65 ganetespib 65 Myelofibrosis 65 immunomodulating 65 CCX# 65 Abatacept 65 ATL# [001] 65 Capecitabine 65 Denufosol 65 BrachySil 65 BZL# 65 multi kinase inhibitor 65 selectively inhibits 65 Eculizumab 65 SAR# [004] 65 fumarate 65 orally bioavailable 65 CTA# 65 anticancer compound 65 renal toxicity 65 Receives Orphan Drug Designation 65 Gefitinib 65 Presents Positive 65 OncoVEX GM CSF 65 Alemtuzumab 65 GSK# [001] 65 Preclinical Data 65 DDP#